CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Carrus Capital Corp Company Snapshot
Carrus Capital Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Carrus Capital Corp with three other pharmaceutical manufacturers in North America: Vericel Corp of the United States (2009 sales of $182,000.00 of which 100% was Autologous Cell Products), InMed Pharmaceuticals Inc (196,000.00 Canadian Dollars [US$154,330.40 ] ), and Aptose Biosciences Inc (184,000.00 Canadian Dollars [US$144,881.60 ] of which 100% was Pharmaceuticals).

Sales Analysis.
   
   
 
  Stock Performance Chart for Carrus Capital Corp
 
  Stock Data: Recent Stock Performance:
  Current Price (7/14/2017): .20
(Figures in Canadian Dollars)
1 Week 66.7%   13 Weeks -25.9%  
4 Weeks -74.7%   52 Weeks n/a  
 
Carrus Capital Corp Key Data:
  Ticker: CHQ Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2009 Sales 198,000
(Year Ending Jan 2010).
Employees: 6
  Currency: Canadian Dollars Market Cap: 598,483
  Fiscal Yr Ends: April Shares Outstanding: 2,992,414
  Share Type: Common Closely Held Shares: 714,286
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.